G-Therapeutics is an EPFL (Ecole Polytechnique Fédérale de Lausanne, Switzerland) spin-off with the aim of making available for human use a fundamentally new treatment paradigm that restored voluntary locomotion in fully paralyzed animals with a success rate of 100%. The company is developing an implantable stimulation system and a robot-assisted training program to rehabilitate individuals with spinal cord injury. The team consisting of several engineers and medical experts has set-up a clinical proof of concept in Human that is planned to start this spring in Lausanne university hospital (CHUV, Switzerland).
Co-founded and organized with Xavier Duportet (MIT – INRIA Constraint Groups), Hello Tomorrow Challenge is a unique event to empower young european innovators (more than 1200 startups selected).
Executive Business Accelerator – Jury of the Hello Tomorrow Challenge, 17 – 18 April 2014.